Cargando…
Health equity necessitates the inclusion of gender identity data in COVID-19 clinical trials
COVID-19 has highlighted the importance of studying differences by sex and gender. The underreporting of gender identity in COVID-19 studies limits the generalizability of study results to nonbinary persons. Some of the data on sex-assigned associated complications of both COVID-19 infection and COV...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10303319/ https://www.ncbi.nlm.nih.gov/pubmed/37391114 http://dx.doi.org/10.1016/j.annepidem.2023.06.024 |
_version_ | 1785065250021703680 |
---|---|
author | Babu, Tara M. Wald, Anna Restar, Arjee J. |
author_facet | Babu, Tara M. Wald, Anna Restar, Arjee J. |
author_sort | Babu, Tara M. |
collection | PubMed |
description | COVID-19 has highlighted the importance of studying differences by sex and gender. The underreporting of gender identity in COVID-19 studies limits the generalizability of study results to nonbinary persons. Some of the data on sex-assigned associated complications of both COVID-19 infection and COVID-19 immunizations is presented in this manuscript. |
format | Online Article Text |
id | pubmed-10303319 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Elsevier Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-103033192023-06-29 Health equity necessitates the inclusion of gender identity data in COVID-19 clinical trials Babu, Tara M. Wald, Anna Restar, Arjee J. Ann Epidemiol Commentary COVID-19 has highlighted the importance of studying differences by sex and gender. The underreporting of gender identity in COVID-19 studies limits the generalizability of study results to nonbinary persons. Some of the data on sex-assigned associated complications of both COVID-19 infection and COVID-19 immunizations is presented in this manuscript. Elsevier Inc. 2023-06-28 /pmc/articles/PMC10303319/ /pubmed/37391114 http://dx.doi.org/10.1016/j.annepidem.2023.06.024 Text en © 2023 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Commentary Babu, Tara M. Wald, Anna Restar, Arjee J. Health equity necessitates the inclusion of gender identity data in COVID-19 clinical trials |
title | Health equity necessitates the inclusion of gender identity data in COVID-19 clinical trials |
title_full | Health equity necessitates the inclusion of gender identity data in COVID-19 clinical trials |
title_fullStr | Health equity necessitates the inclusion of gender identity data in COVID-19 clinical trials |
title_full_unstemmed | Health equity necessitates the inclusion of gender identity data in COVID-19 clinical trials |
title_short | Health equity necessitates the inclusion of gender identity data in COVID-19 clinical trials |
title_sort | health equity necessitates the inclusion of gender identity data in covid-19 clinical trials |
topic | Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10303319/ https://www.ncbi.nlm.nih.gov/pubmed/37391114 http://dx.doi.org/10.1016/j.annepidem.2023.06.024 |
work_keys_str_mv | AT babutaram healthequitynecessitatestheinclusionofgenderidentitydataincovid19clinicaltrials AT waldanna healthequitynecessitatestheinclusionofgenderidentitydataincovid19clinicaltrials AT restararjeej healthequitynecessitatestheinclusionofgenderidentitydataincovid19clinicaltrials |